The Translational Genomics Research Institute (TGen) has identified a protein called SGEF that promotes the survival of glioblastoma (GBM) tumor cells and helps the...
A completely new treatment for glioblastoma, which combines a common chemotherapy agent with T cells, may enter clinical trials following highly successful mouse-model studies....